Expression of N6-methyladenosine (m6A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL)-Reference-Cited by-同舟云学术

Expression of N6-methyladenosine (m6A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL)

Published:2021-01-01 Issue:1 Volume:12 Page:6115-6133
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Xie Zucheng¹,Li Meiwei¹,Hong Haoyuan¹,Xu Qingyuan¹,He Zhendong¹,Peng Zhigang¹

Affiliation:

1. Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China

Funder

the International Scientific Exchange Foundation of China Project

the China Anti-cancer Association Project

the Appropriate Hygiene Technology Development, Popularization and Application Project of Guangxi, China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1972644

Reference68 articles.

1. Cancer Statistics, 2021

2. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

3. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

4. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

5. Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NEAT1 and CHROMR lncRNAs: a promising diagnostic tool for diffuse large B-cell lymphoma especially in elderly patients;Biomarkers in Medicine;2024-08-17

2. The Potential of Exosomes for Osteoporosis Treatment: A Review;Drug Design, Development and Therapy;2024-03

3. Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphoma: A review;Medicine;2023-11-10

4. KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway;Cellular & Molecular Biology Letters;2023-04-19

5. Retracted: METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B‐cell lymphoma cells;Immunity, Inflammation and Disease;2023-02